Ajanta Pharma looking good

Updated
The stock has taken a support at 2175 around and can go upwards from here.
Talking about fundamental analysis, the stock has a net profit margin which fluctuates between 15-20% on yearly basis which is good for investment. The revenue has been increasing continuously for the past 5 years and the net profit looks good too.

Talking about the technical analysis, the stock is not in the overbought zone and has taken a support on the weekly chart itself.

CMP 2311
Can be held for a medium to long term perspective.

Note: This is not an investment advice, it is just an educational study from my perspective. I am not SEBI registered.
Trade closed: target reached
Target reached successfully and even beyond that. I hope everybody booked their profits today. As the markets are very unstable, I am not taking any new trades. I would advice everyone to do the same but you are free to do whatever you want.
Note: This is not a recommendation and I am not SEBI registered.
ajantapharmaAJANTPHARMFundamental AnalysisTechnical IndicatorsTrend Analysis

Disclaimer